|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,541,775 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-01-04 |
4 |
D |
$4.45 |
$12,745 |
D/D |
(2,864) |
38,591 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2010-01-04 |
4 |
OE |
$3.78 |
$11,905 |
D/D |
3,147 |
41,455 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-01-04 |
4 |
D |
$4.45 |
$17,101 |
D/D |
(3,843) |
43,898 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-01-04 |
4 |
OE |
$3.78 |
$15,976 |
D/D |
4,223 |
47,741 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2009-10-16 |
4 |
B |
$4.88 |
$90,243 |
D/D |
18,500 |
804,942 |
4.01 |
- |
|
Olson William C |
VP, Research & Development |
|
2009-10-01 |
4 |
D |
$5.01 |
$11,548 |
D/D |
(2,305) |
36,910 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2009-10-01 |
4 |
OE |
$4.26 |
$10,788 |
D/D |
2,533 |
39,215 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-10-01 |
4 |
D |
$5.01 |
$12,154 |
D/D |
(2,426) |
35,951 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-10-01 |
4 |
OE |
$4.26 |
$11,354 |
D/D |
2,666 |
38,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-10-01 |
4 |
D |
$5.01 |
$16,313 |
D/D |
(3,256) |
43,270 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-10-01 |
4 |
OE |
$4.26 |
$15,239 |
D/D |
3,578 |
46,526 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-10-01 |
4 |
D |
$5.01 |
$12,154 |
D/D |
(2,426) |
38,060 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-10-01 |
4 |
OE |
$4.26 |
$11,354 |
D/D |
2,666 |
40,486 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-10-01 |
4 |
D |
$5.01 |
$18,231 |
D/D |
(3,639) |
29,915 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-10-01 |
4 |
OE |
$4.26 |
$17,032 |
D/D |
3,999 |
33,554 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2009-06-23 |
4 |
AS |
$4.73 |
$9,468 |
D/D |
(2,000) |
36,699 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2009-06-23 |
4 |
AS |
$4.73 |
$11,815 |
D/D |
(2,500) |
35,677 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-06-19 |
4 |
AS |
$5.25 |
$26,265 |
D/D |
(5,000) |
34,590 |
|
- |
|
Williams Nicole |
Director |
|
2009-04-21 |
4 |
A |
$5.29 |
$26,984 |
D/D |
5,000 |
5,000 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-04-01 |
4 |
OE |
$5.65 |
$17,967 |
D/D |
3,180 |
27,942 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2009-04-01 |
4 |
D |
$6.65 |
$19,238 |
D/D |
(2,893) |
24,762 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
39,590 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2009-04-01 |
4 |
D |
$6.65 |
$12,828 |
D/D |
(1,929) |
37,470 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-04-01 |
4 |
OE |
$5.65 |
$16,074 |
D/D |
2,845 |
41,785 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2009-04-01 |
4 |
D |
$6.65 |
$17,210 |
D/D |
(2,588) |
38,940 |
|
- |
|
801 Records found
|
|
Page 9 of 33 |
|
|